217 related articles for article (PubMed ID: 38574169)
1. Health state utility values ranges across varying stages and severity of type 2 diabetes-related complications: A systematic review.
Tan MHP; Ong SC; Tahir NAM; Ali AM; Mustafa N
PLoS One; 2024; 19(4):e0297589. PubMed ID: 38574169
[TBL] [Abstract][Full Text] [Related]
2. Quantifying health-related quality of life in Malaysian type 2 diabetes: focusing on complication types and severity.
Tan MHP; Ong SC; Vasan Thakumar A; Mustafa N
Qual Life Res; 2023 Jul; 32(7):1925-1941. PubMed ID: 36781810
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
Paracha N; Abdulla A; MacGilchrist KS
Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
[TBL] [Abstract][Full Text] [Related]
5. Health State Utility Values Associated with Cochlear Implants in Adults: A Systematic Review and Network Meta-Analysis.
Dixon PR; Shapiro J; Tomlinson G; Cottrell J; Lui JT; Falk L; Chen JM
Ear Hear; 2023 Mar-Apr 01; 44(2):244-253. PubMed ID: 36303282
[TBL] [Abstract][Full Text] [Related]
6. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the health-related quality of life of patients with type 2 diabetes in relation to macrovascular and microvascular complications.
Tan MHP; Ong SC; Bujang MA; Shah SA; Mustafa N
Acta Diabetol; 2023 Dec; 60(12):1735-1747. PubMed ID: 37542199
[TBL] [Abstract][Full Text] [Related]
8. The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya.
Patel AR; Lester RT; Marra CA; van der Kop ML; Ritvo P; Engel L; Karanja S; Lynd LD
Health Qual Life Outcomes; 2017 Jul; 15(1):143. PubMed ID: 28716065
[TBL] [Abstract][Full Text] [Related]
9. Health utilities and quality of life in individuals with tuberous sclerosis complex (TSC) who experience epileptic seizures: A web-based survey.
Tritton T; Bennett B; Brohan E; Grant L; Cooper A; Fladrowski C; Evanochko C; Neary M; Vieira J; Buffa V; Kingswood C
Epilepsy Behav; 2019 Mar; 92():213-220. PubMed ID: 30690322
[TBL] [Abstract][Full Text] [Related]
10. Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation.
Shao H; Yang S; Fonseca V; Stoecker C; Shi L
Pharmacoeconomics; 2019 Jul; 37(7):921-929. PubMed ID: 30778865
[TBL] [Abstract][Full Text] [Related]
11. Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis.
Sampson CJ; Tosh JC; Cheyne CP; Broadbent D; James M
Syst Rev; 2015 Feb; 4():15. PubMed ID: 25875206
[TBL] [Abstract][Full Text] [Related]
12. Utility estimates for patients with Type 2 diabetes mellitus after experiencing a myocardial infarction or stroke: a systematic review.
Brennan VK; Mauskopf J; Colosia AD; Copley-Merriman C; Hass B; Palencia R
Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):111-23. PubMed ID: 25555462
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
14. Review of utility values for economic modeling in type 2 diabetes.
Beaudet A; Clegg J; Thuresson PO; Lloyd A; McEwan P
Value Health; 2014 Jun; 17(4):462-70. PubMed ID: 24969008
[TBL] [Abstract][Full Text] [Related]
15. Health State Utility Values for Type 2 Diabetes and Related Complications in East and Southeast Asia: A Systematic Review and Meta-Analysis.
Mok CH; Kwok HHY; Ng CS; Leung GM; Quan J
Value Health; 2021 Jul; 24(7):1059-1067. PubMed ID: 34243830
[TBL] [Abstract][Full Text] [Related]
16. Health State Utility Values in Juvenile Idiopathic Arthritis: What is the Evidence?
Grazziotin LR; Currie G; Kip MMA; IJzerman MJ; Twilt M; Lee R; Marshall DA
Pharmacoeconomics; 2020 Sep; 38(9):913-926. PubMed ID: 32390065
[TBL] [Abstract][Full Text] [Related]
17. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L.
Takahara M; Katakami N; Shiraiwa T; Abe K; Ayame H; Ishimaru Y; Iwamoto M; Shimizu M; Tomonaga O; Yokoyama H; Matsuoka TA; Shimomura I
Acta Diabetol; 2019 Mar; 56(3):309-319. PubMed ID: 30353354
[TBL] [Abstract][Full Text] [Related]
19. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Hemmingsen B; Gimenez-Perez G; Mauricio D; Roqué I Figuls M; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003054. PubMed ID: 29205264
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
